Intra-DRG list updated in France

In France, certain medical devices are financed within the DRG tariff but require an explicit review of clinical evidence by the National Commission for the Evaluation of Medical Devices and Health Technologies CNEDiMTS to ensure that they are safe and effective. This mechanism is called “intra-DRG (intra-GHS) coverage”. The mechanism is applicable to particularly invasive devices. Only devices listed in the intra-DRG list can be purchased by hospitals. 

On October 4, 2024, the updated version of the intra-DRG list of October 1, 2024, was published. 

Three new devices were registered under Title I, “Cardiac and vascular implants”: 

• Aortic valve bioprosthesis with frame Avalus Ultra by Medtronic;
• Thrombo-aspiration catheter Sofia Flow 88 by Microvention Europe;
• Thrombo-aspiration catheter Cereglide 71 by Johnson & Johnson.

Furthermore, one device was removed from the list, and the registration conditions for several devices were changed.

See the more details in French here. 

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.